Health · Healthcare & Policy · 3 hrs ago
Bioengineered Liver System Found Safe in Small Phase I Trial
A single-use bioengineered liver system was tested in a small phase I trial.
It was studied in patients with syndromes of liver failure.
The system connects to an external blood circuit that replicates key liver functions.
Phase I trials test a treatment’s safety at an early stage.
The system was found to be safe in this trial.
The findings do not establish whether it works as a treatment, and no next steps are stated.
A small phase I trial found a single-use bioengineered liver system safe among patients with syndromes of liver failure.
The system pairs the bioengineered liver with an extracorporeal blood circuit.
The circuit replicates key functions of a human liver.
The report was published by MedPage Today on November 10, 2026.
- Who
- Patients with syndromes of liver failure took part in the trial.
- What
- A small phase I trial found a single-use bioengineered liver system safe.
- When
- The report was published November 10, 2026.
- Where
- Not stated.
- Why
- The system was designed to replicate key functions of a human liver.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Trial phase
- Phase I
- Trial size
- Small
- System
- Single-use bioengineered liver paired with an extracorporeal blood circuit
- Trial finding
- Shown to be safe among patients with syndromes of liver failure
- Publication date
- November 10, 2026